Search - Prime Therapeutics
-
New report highlights value-based contract solution and analysis of top 10 drug classes impacting Medicaid pharmacy net trend
PA Sub-Categories: Specialty drugs Products Prime Article: Stories -
Insights from Academy of Managed Care Pharmacy (AMCP) Nexus 2023
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Perspectives High-Cost Therapy Profile: June 2024 Detailed information about Imetelstat Intravenous (IV) June 14, 2024 High Cost Therapy Profile Oncology Imetelstat Intravenous (IV) Geron Proposed...
-
publications 2024 Employer Market Insights Report June 28, 2024 Prime is pleased to present the seventh edition of the Employer Market Insights Report. Within this one-of-a-kind publication,...
-
Cover image for FDA Decisions Expected_February 2025 Drug pipeline for February 2025 Prime Therapeutics /fda-decisions-expected-february-2025 About Prime Therapeutics Prime Therapeutics logo Prime...
Prime Article: Research & Publications PA Research & Publications: FDA Decisions Expected -
publications High-Cost Therapy Profile: February 2025 Revakinagene taroretcel Ocular implant | Neurotech Pharmaceuticals, Inc. Ophthalmology February 13, 2025 Proposed indications Macular...
-
Event features Pat Gleason, AVP, health outcomes at Prime Therapeutics
Prime Article: Events